Vyleesi
An FDA-approved drug that targets the melanocortin pathway to enhance libido in females. It is injectable and can cause hyperpigmentation in some women.
Common Themes
Videos Mentioning Vyleesi
Improving Sexual & Urological Health in Males and Females | Dr. Rena Malik
Andrew Huberman
An FDA-approved injectable medication for premenopausal women with hypoactive sexual desire disorder, acting as a melanocortin receptor agonist to increase desire.
What causes erectile dysfunction and what can be done to treat it? | Peter Attia & Mohit Khera
Peter Attia MD
A medication for female sexual dysfunction.
How to Navigate Menopause & Perimenopause for Maximum Health & Vitality | Dr. Mary Claire Haver
Andrew Huberman
An FDA-approved injectable medication for libido in women, administered 30 minutes before sexual activity, acting on the alpha melanocortin stimulating hormone pathway.
Male vs. Female Brain Differences & How They Arise From Genes & Hormones | Dr. Nirao Shah
Andrew Huberman
An FDA-approved drug that targets the melanocortin pathway to enhance libido in females. It is injectable and can cause hyperpigmentation in some women.
259 - Women's sexual health: Why it matters, what can go wrong, and how to fix it
Peter Attia MD
An FDA-approved, self-injected drug for HSDD in premenopausal women, taken on demand 45 minutes before sexual activity. It's a melanocortin receptor agonist stimulating dopaminergic pathways.
Peptide & Hormone Therapies for Health, Performance & Longevity | Dr. Craig Koniver
Andrew Huberman
The brand name for PT-41, an FDA-approved drug for female hypoactive sexual desire disorder.